Physician

Carlos E Marchini, MD

According to 2025 Medicare claims, Carlos Marchini, MD (NPI: 1720088677) practices pulmonary disease in the Grants Pass, OR market, with the plurality of this provider's patient population coming from Josephine, OR. This provider's primary affiliated billing organization is LUNG CLINIC CENTER FOR SLEEP MEDICINE (NPI: 1114019494; TIN: 43-2087792) and primary practice location at 97526-1635.

Marchini's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 263 traditional Medicare patients, billed 1,242 HCPCS/CPT codes, and received $79,431 in Medicare payments. The top billing code was 99215 (Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more). Part D data shows 2,300 prescription claims across 313 beneficiaries totaling $742,915 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 2,767 claims. Open Payments data shows 10 records totaling $795. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $160,546 to $79,431. In contrast, Part D prescription costs have risen steadily, from $564,023 to $742,915. For DME billing, reported payments did not follow a clear longitudinal pattern.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$80K$161K2015 Medicare payment: $160,546 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $141,221 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $129,993 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $120,684 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $118,700 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $96,587 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $102,661 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $90,531 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $94,115 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $79,431 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20157482,794$160,546
20167062,763$141,221
20174732,294$129,993
20184252,043$120,684
20193761,826$118,700
20203601,552$96,587
20213251,543$102,661
20222991,589$90,531
20232881,420$94,115
20242631,242$79,431

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$407K$815K2015 Drug cost: $564,023 (USD; Tot_Drug_Cst)2016 Drug cost: $496,893 (USD; Tot_Drug_Cst)2017 Drug cost: $541,294 (USD; Tot_Drug_Cst)2018 Drug cost: $499,648 (USD; Tot_Drug_Cst)2019 Drug cost: $469,823 (USD; Tot_Drug_Cst)2020 Drug cost: $501,650 (USD; Tot_Drug_Cst)2021 Drug cost: $811,035 (USD; Tot_Drug_Cst)2022 Drug cost: $814,610 (USD; Tot_Drug_Cst)2023 Drug cost: $629,355 (USD; Tot_Drug_Cst)2024 Drug cost: $742,915 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
20152501,707$564,023
20162381,536$496,893
20172261,710$541,294
20182351,727$499,648
20192471,778$469,823
20202441,840$501,650
20212501,949$811,035
20222792,043$814,610
20232781,926$629,355
20243132,300$742,915

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

DME Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: DME_Suplr_Mdcr_Pymt_Amt. Source: Medicare DME, Devices & Supplies by Referring Provider.0$137K$274K2015 Medicare payment: $274,102 (USD; DME_Suplr_Mdcr_Pymt_Amt)2016 Medicare payment: $187,305 (USD; DME_Suplr_Mdcr_Pymt_Amt)2017 Medicare payment: $142,207 (USD; DME_Suplr_Mdcr_Pymt_Amt)2018 Medicare payment: $125,988 (USD; DME_Suplr_Mdcr_Pymt_Amt)2019 Medicare payment: $158,067 (USD; DME_Suplr_Mdcr_Pymt_Amt)2020 Medicare payment: $171,145 (USD; DME_Suplr_Mdcr_Pymt_Amt)2021 Medicare payment: $143,367 (USD; DME_Suplr_Mdcr_Pymt_Amt)2022 Medicare payment: $165,720 (USD; DME_Suplr_Mdcr_Pymt_Amt)2023 Medicare payment: $143,215 (USD; DME_Suplr_Mdcr_Pymt_Amt)2024 Medicare payment: $126,965 (USD; DME_Suplr_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClaimsPayment
20151,1643,678$274,102
20161,1193,414$187,305
20171,2463,382$142,207
20181,2653,474$125,988
20191,2953,726$158,067
20201,2103,645$171,145
20211,1493,367$143,367
20221,0363,183$165,720
20239962,815$143,215
20248932,767$126,965

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99215Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more221364$114
95800Sleep study including heart rate, breathing, and sleep time119160$90
94060Test to measure expiratory airflow and volume changes before and after medication administration265410$25
94762Test to measure oxygen level in blood using ear or finger device continuously overnight74109$16
93040Electrocardiogram (ecg) 1 to 3 leads with review by physician7677$9

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Trelegy ElliptaFluticasone/Umeclidin/Vilanter1115,250$107,653
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr1416,150$88,766
Prolastin CAlpha-1-Proteinase Inhibitor12319$76,918
Spiriva RespimatTiotropium Bromide823,720$63,224
Dupixent PenDupilumab12336$42,170

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS CodeHCPCS DescriptionSupplier Rental IndicatorTotal Supplier BeneficiariesTotal Supplier ClaimsTotal Medicare Payment Amount
E0466Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)YN/R21$21,014
E1390Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rateY26205$14,694
A7032Cushion for use on nasal mask interface, replacement only, eachN46123$12,360
A7034Nasal interface (mask or cannula type) used with positive airway pressure device, with or without head strapN85224$11,750
A7031Face mask interface, replacement for full face mask, eachN39104$9,078

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.10$795Bayer Healthcare Pharmaceuticals Inc.
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Carlos E. Marchini, MD?

Tedicare shows public-source Medicare data for Carlos E. Marchini, MD (NPI 1720088677), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Carlos E. Marchini, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Carlos E. Marchini, MD?

Carlos E. Marchini, MD is linked to LUNG CLINIC CENTER FOR SLEEP MEDICINE (billing NPI 1114019494) in the available physician profile data.

Does Carlos E. Marchini, MD have Open Payments data?

Carlos E. Marchini, MD has 10 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.